Mayo CCCG (Supp) - Impact of Multi-Channel Communication Campaigns on Cancer Prevention, Control and Survivorship (CaPCaS) in Black, Hispanic, Rural, and Sexual and Gender Minority Populations

Project: Research project

Project Details

Description

ABSTRACT This application is being submitted by the Mayo Clinic Comprehensive Cancer Center (MCCCC) to extend the period of support for the P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations. The MICEO program will continue to be coordinated by the MCCCC Community Outreach & Engagement (COE) Office and Programs in three MCCCC catchment areas (CAs): Arizona (AZ), Florida (FL), and the Midwest/Mayo Clinic Health Systems (MCHS). The MICEO extension builds on the significant progress made through the initial MICEO funding period. As of June 2024, our reach includes 100+ Hispanic adults in Arizona (AZ) CA, 500+ Black men in Florida (FL) CA, and 100+ rural adults in the Midwest/MCHS CA. We developed and published the Cancer Advocacy Handbook in both English and Spanish, with a total of 25 community health educators (CHEs) trained. Additionally, 25 advocates from other Cancer Centers were trained during the Science of COE Conference, co- organized by the MCCCC. Focusing on colorectal, liver, lung, and prostate cancers, multi-channel communication activities were provided to at least 1,000+ general population aged 30 years and above across the cancer care continuum. The distribution channels employed included print media, virtual tools (including the Mayo Clinic Connect platform), and both virtual and hybrid events and meetings (cancer conversations), as well as interpersonal communications (Health Fairs, Farmers Markets, Churches). The primary goal of the initial (ongoing) supplement was to assess the impact of multi-channel communication campaigns targeting Black, Hispanic, and Rural populations on cancer prevention, control, and survivorship (CaPCaS). The proposed supplement extension project will continue to focus on Track 2, targeting the general population aged 30 years and above. Specifically, the extension will continue efforts for the implementation, sustainability, and evaluation of the MICEO initiatives across the MCCCC enterprise focusing on: Black men (prostate cancer), Hispanic adults (colorectal and liver cancers), rural-residing adults (lung and colorectal cancers), and expansion to include Sexual and Gender Minority health. This extension will enable us to further assess the impact of multi- channel communication campaigns targeting Black, Hispanic, Rural, and Sexual and Gender Minority populations on cancer prevention, control, and survivorship (CaPCaS). The specific aims of this extension are to: (1) expand the implementation of culturally tailored multi-channel communication campaigns for targeted populations enterprise-wide; (2) foster continuous improvement of MICEO activities based on comprehensive evaluations focused on assessing the effectiveness of the campaigns; and (3) foster the dissemination, replicability and sustainability of the MCCCC MICEO initiatives through community and partnership engagements of local organizations, faith-based organizations. healthcare providers, and other educational institutions.
StatusActive
Effective start/end date3/1/852/28/25

Funding

  • National Cancer Institute: $5,730,127.00
  • National Cancer Institute: $5,235,021.00
  • National Cancer Institute: $5,733,847.00
  • National Cancer Institute: $5,730,127.00
  • National Cancer Institute: $98,232.00
  • National Cancer Institute: $49,999.00
  • National Cancer Institute: $5,126,516.00
  • National Cancer Institute: $110,040.00
  • National Cancer Institute: $3,720.00
  • National Cancer Institute: $5,104,634.00
  • National Cancer Institute: $200,000.00
  • National Cancer Institute: $200,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.